This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Benign neoplasm: Liver/bile ducts (ICD-9)
CD2_BENIGN_LIVER_BILE_9
biliary tract neoplasm: A neoplasm that involves the biliary tract.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
33 |
4. Check minimum number of eventsNone |
33 |
5. Include endpointsNone |
33 |
6. Filter based on genotype QC (FinnGen only) |
33 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Liver/bile ducts (ICD-9)
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Liver/bile ducts (ICD-9)
- Benign neoplasm: Small intestine
- Benign neoplasm: Small intestine
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 33 | 25 | 8 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | 39.98 | 37.45 | 47.88 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004119) Hemoglobin [Mass/volume] in Venous blood
6
10
7.04
2.83
2.0
2.5
g/l
117.0
128.3
—
6
10
(3027273) Bicarbonate [Moles/volume] in Venous blood
5
7
8.14
2.64
2.6
1.9
mmol/l
24.7
26.2
—
5
7
(3026008) Bacteria identified in Urine by Culture
17
90
2.83
2.17
3.5
2.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
9
37
2.96
1.64
3.0
2.0
umol/l
15.9
11.3
—
9
32
(3012544) pH of Venous blood
6
21
3.25
1.58
4.2
3.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
16
95
2.33
1.49
3.5
3.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
5
16
3.49
1.49
9.2
10.4
mmol/l
24.3
26.4
—
5
16
(3003458) Phosphate [Moles/volume] in Serum or Plasma
8
36
2.60
1.36
6.6
3.7
mmol/l
1.2
1.0
—
8
30
(3000991) Gas panel - Venous blood
5
18
3.08
1.33
4.8
8.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
12
68
2.20
1.20
1.2
1.6
nmol/l
17.9
22.9
0.39
12
56
(3015736) pH of Urine
15
94
2.09
1.17
3.5
3.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
7
32
2.50
1.16
1.9
3.1
umol/l
4.3
10.8
—
7
27
(3002173) Hemoglobin [Mass/volume] in Arterial blood
5
21
2.62
1.13
5.8
10.4
g/l
121.2
121.8
—
5
21
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
20
145
1.96
1.00
5.5
7.9
umol/l
27.7
10.0
0.48
20
138
(3000494) Fungus identified in Specimen by Culture
6
28
2.39
0.97
1.3
1.5
—
—
—
0
0
(3013512) EKG study
12
74
1.98
0.94
2.0
3.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
12
74
1.98
0.94
2.3
2.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
8
45
2.02
0.93
1.1
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9
54
1.91
0.84
2.2
2.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
14
96
1.80
0.78
3.6
4.2
e6/l
552.9
50.8
—
8
75
(3016502) Oxygen saturation in Arterial blood
5
24
2.27
0.78
5.8
9.6
%
96.9
95.2
—
5
24
(36304419) Bacteria [Presence] in Urine
12
79
1.82
0.76
3.5
3.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
13
89
1.76
0.72
3.3
3.7
e6/l
34.9
15.1
—
8
72
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
15
109
1.69
0.67
3.4
4.3
—
—
—
0
0
(3002256) Pathology report gross observation
5
29
1.85
0.66
1.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
0
23
0.00
0.60
0.0
1.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
11
78
1.62
0.51
3.6
3.8
e6/l
0.8
0.4
—
6
62
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
8
55
1.60
0.48
2.4
4.0
mmol/l
2.5
2.5
—
8
46
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
13
98
1.54
0.47
3.6
3.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
15
119
1.48
0.42
4.4
3.7
ng/l
29.9
24.2
—
9
82
(3037467) Urinalysis macro (dipstick) panel - Urine
21
180
1.46
0.38
3.9
4.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
7
52
1.44
0.34
1.6
6.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
11
85
1.44
0.33
6.7
4.0
—
7.4
—
0
17
(3023368) Bacteria identified in Blood by Culture
10
77
1.43
0.30
2.5
4.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
9
72
1.34
0.29
1.9
3.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
6
80
0.70
0.28
3.3
3.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
5
42
1.22
0.22
3.2
3.5
mmol/l
0.8
0.8
—
5
36
(3049717) Cytology report of Urine Cyto stain
0
11
0.00
0.22
0.0
3.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
10
0.00
0.22
0.0
2.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
7
59
1.24
0.20
5.3
3.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
14
123
1.24
0.16
2.1
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
14
125
1.21
0.13
5.6
4.6
—
0.0
—
0
29
(42870588) Differential panel, method unspecified - Blood
10
87
1.21
0.11
3.0
4.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
5
44
1.16
0.10
1.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
13
143
0.85
0.10
3.3
2.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
28
267
1.32
0.09
17.3
14.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
25
240
1.17
0.08
15.8
15.3
ml/min/173m2
69.6
76.2
0.44
16
196
(3009542) Hematocrit [Volume Fraction] of Blood
22
227
0.91
0.02
22.5
15.2
%
40.5
39.9
0.18
12
156
(3044889) 12 lead EKG panel
18
179
1.01
0.00
6.4
3.8
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4094501)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
7
0.00
0.00
0.0
1.3
—
4.6
—
0
7
(1616796) Gas panel - Central venous blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.7
—
22.7
—
0
7
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
9.1
—
0
5
(4281824)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
6
67
0.87
0.00
2.8
3.0
umol/l
349.0
318.8
—
6
54
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036489) Thrombin time
0
5
0.00
0.00
0.0
1.8
—
19.0
—
0
5
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.3
—
61.4
—
0
7
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
7
72
0.96
0.00
6.4
8.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_LIVER_BILE_9 – Benign neoplasm: Liver/bile ducts (ICD-9)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).